Translate Bio, Inc. 4 SEC Filings

Filed On	Filing
14 Sep 2021	Form 4: Sutherland Everett Rand, President Disposed of 300,000 Stock Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Smith Brendan, Chief Financial Officer Disposed of 201,800 Stcok Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Renaud Ronald C Jr, Director Sold 954,053 shares ($36.3M) · Disposed of 2,186,005 Stock Option (right to buy) (Open Market Sale) · Disposed of 325,000 Stcok Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Burgess Paul D., Chief Operating Officer, CLO Sold 71,833 shares ($2.73M) · Disposed of 679,605 Stock Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Plenge Robert M, Director Disposed of 95,600 Stock Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Meyer Robert J., Director Disposed of 95,600 Stock Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Hughes Owen, Director Sold 29,860 shares ($1.13M) · Disposed of 75,935 Stock Option (right to buy) (Open Market Sale) · Disposed of 20,000 Stock Option (righ to buy) (Open Market Sale)
14 Sep 2021	Form 4: Demetri George, Director Disposed of 76,700 Stock Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Formela Jean Francois, Director Sold 2,055,063 shares ($78.1M) · Disposed of 95,600 Stock Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Demetri George, Director Disposed of 76,700 Stock Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Beckman Daniella, Director Disposed of 125,795 Stock Option (right to buy) (Open Market Sale)
14 Sep 2021	Form 4: Sanofi, 10% owner Bought 71,983,597 shares ($2.74B)
17 Jun 2021	Form 4: Formela Jean Francois, Director Granted 20,000 Common Stock (right to buy)
16 Jun 2021	Form 4: Beckman Daniella, Director Granted 20,000 Stock Option (right to buy)
16 Jun 2021	Form 4: Plenge Robert M, Director Granted 20,000 Stock Option (right to buy)
16 Jun 2021	Form 4: Meyer Robert J., Director Granted 20,000 Stock Option (right to buy)
16 Jun 2021	Form 4: Hughes Owen, Director Granted 20,000 Stock Option (right to buy)
16 Jun 2021	Form 4: Demetri George, Director Granted 20,000 Stock Option (right to buy)
20 Apr 2021	Form 4: Smith Brendan, Chief Financial Officer Granted 201,800 Stock Option (Right to Buy)
09 Apr 2021	Form 4: Renaud Ronald C Jr, Director Received 9,026 shares by exercise or conversion ($66.7K)

Comments